Analyst Price Target is $20.00
▲ +61.16% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Electromed in the last 3 months. The average price target is $20.00, with a high forecast of $20.00 and a low forecast of $20.00. The average price target represents a 61.16% upside from the last price of $12.41.
Current Consensus is
The current consensus among 2 contributing investment analysts is to buy stock in Electromed.
Electromed, Inc. engages in the development, manufacture, marketing, and sale of medical equipment. The firm's products include SmartVest SQL System and SmartVest Connect. It focuses on building market awareness, and acceptance of its products and services with physicians, clinicians, patients, and third-party payers. The company was founded by Robert D. Hansen and Craig N. Hansen in 1992 and is headquartered in New Prague, MN.